Publication & Citation Trends
Publications
211 total
Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV‐1 and end‐stage kidney disease on chronic haemodialysis OA
Cited by 2
Semantic Scholar
Efficacy, Safety, and Tolerability of Switching From Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine Among Adults With Virologically Suppressed HIV: The DYAD Study
Cited by 13
Semantic Scholar
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study.
Cited by 28
Semantic Scholar
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting OA
Cited by 3
Semantic Scholar
1603. Efficacy, safety and tolerability of switching to dolutegravir/lamivudine in virologically suppressed adults living with HIV on bictegravir/emtricitabine/tenofovir alafenamide -the DYAD study OA
Cited by 2
Semantic Scholar
1596. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results OA
Cited by 5
Semantic Scholar
Racial/ethnic disparities in HIV care outcomes among insured patients at a large urban sexual health clinic
Cited by 5
Semantic Scholar
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials OA
Cited by 70
Semantic Scholar
Research Topics
HIV/AIDS drug development and treatment
(180)
HIV Research and Treatment
(158)
HIV/AIDS Research and Interventions
(92)
HIV-related health complications and treatments
(59)
Hepatitis C virus research
(23)
Affiliations
University of Central Florida
AIDS Healthcare Foundation
The Lundquist Institute
BCS — The Chartered Institute for IT
Fondation pour la Recherche Stratégique